• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    2/14/24 10:02:59 AM ET
    $ISRG
    Industrial Specialties
    Health Care
    Get the next $ISRG alert in real time by email
    SC 13G/A 1 isrg13gadec23.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10) INTUITIVE SURGICAL INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46120E602 (CUSIP NUMBER) December 31, 2023 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 7,799,785 6. Shared Voting Power* 0 7. Sole Dispositive Power* 16,940,556 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 16,990,447 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 4.8% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: INTUITIVE SURGICAL INC Item 1(b) Address of Issuer's Principal Executive Offices: 1020 KIFER ROAD, SUNNYVALE, CALIFORNIA 94086 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. (Price Associates) Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 46120E602 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2024 Signature: /s/ Armando Capasso Name & Title: Armando Capasso, Vice President 12/31/2023
    Get the next $ISRG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ISRG

    DatePrice TargetRatingAnalyst
    12/2/2024$522.00 → $650.00Equal-Weight → Overweight
    Morgan Stanley
    8/2/2024$380.00 → $510.00Neutral → Buy
    Redburn Atlantic
    7/10/2024$462.00 → $512.00Buy
    Citigroup
    5/30/2024$500.00Buy
    Goldman
    11/17/2023$318.00Buy
    HSBC Securities
    7/19/2023$377.00Outperform
    Robert W. Baird
    4/19/2023$240.00 → $270.00In-line
    Evercore ISI
    4/19/2023$305.00 → $317.00Buy
    Citigroup
    More analyst ratings

    $ISRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/24 10:02:59 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/23 12:37:59 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/9/23 11:22:22 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ISRG
    Financials

    Live finance-specific insights

    See more

    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Intuitive Surgical upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Intuitive Surgical from Equal-Weight to Overweight and set a new price target of $650.00 from $522.00 previously

      12/2/24 6:57:53 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Redburn Atlantic with a new price target

      Redburn Atlantic upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $510.00 from $380.00 previously

      8/2/24 7:32:46 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Citigroup reiterated coverage on Intuitive Surgical with a new price target

      Citigroup reiterated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $512.00 from $462.00 previously

      7/10/24 8:37:42 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SVP & Chief Mfg and Supply Cha Brosius Mark sold $23,596 worth of shares (42 units at $561.81), decreasing direct ownership by 2% to 1,983 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      5/16/25 6:58:53 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SVP & Chief Mfg and Supply Cha Brosius Mark sold $36,886 worth of shares (66 units at $558.88), decreasing direct ownership by 3% to 2,025 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      5/14/25 6:18:09 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Officer Samath Jamie exercised 915 shares at a strike of $259.91 and sold $483,074 worth of shares (915 units at $527.95) (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      5/5/25 4:43:58 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces First Quarter Earnings

      SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the first quarter of 2024.The Company placed 367 da Vinci surgical systems, compared with 313 in the first quarter of 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vinci 5 systems, compared with 8 in the first quarter of 2024.The Company grew its da Vinci surgical system installed base to 10,189 systems as of Mar

      4/22/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Fourth Quarter Earnings

      SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2024. Q4 Highlights Worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.The Company placed 493 da Vinci surgical systems, compared with 415 in the fourth quarter of 2023. The fourth quarter 2024 da Vinci surgical system placements included 174 da Vinci 5 systems.The Company grew its da Vinci surgical system installed base to 9,902 systems as of December 31, 2024, an increase of 15%

      1/23/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results

      SUNNYVALE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2024 financial results ahead of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. Financial and Operational Highlights Fourth quarter 2024 worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.Full year 2024 worldwide da Vinci procedures grew approximately 17% compared with 2023. The Company expects worldwide da Vinci procedures to i

      1/15/25 9:00:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces CEO Transition Effective July 1, 2025

      President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

      5/15/25 9:05:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection

      SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the da Vinci SP's capabilities in colorectal surgery, building upon procedures previously cleared by the FDA in November 2024, which include transabdominal procedures - low anterior resection, total mesorec

      5/1/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces First Quarter Earnings

      SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the first quarter of 2024.The Company placed 367 da Vinci surgical systems, compared with 313 in the first quarter of 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vinci 5 systems, compared with 8 in the first quarter of 2024.The Company grew its da Vinci surgical system installed base to 10,189 systems as of Mar

      4/22/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Leadership Updates

    Live Leadership Updates

    See more
    • Intuitive Announces CEO Transition Effective July 1, 2025

      President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

      5/15/25 9:05:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance
    • Astera Labs Appoints Dr. Craig Barratt to Board of Directors

      SANTA CLARA, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced the appointment of Dr. Craig Barratt to its Board of Directors. Dr. Barratt is a seasoned technology industry veteran with decades of experience as an impactful leader and board member at networking, semiconductor, and medical device companies. "Craig's proven track record of scaling high-growth technology companies and driving breakthrough innovations at industry leaders like Atheros, Google, and Qualcomm makes him an invaluable addition to Astera Labs' Board of Directors," said Jitendra Moh

      3/3/25 4:05:00 PM ET
      $ALAB
      $ISRG
      Semiconductors
      Technology
      Industrial Specialties
      Health Care

    $ISRG
    SEC Filings

    See more
    • Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      5/15/25 9:05:20 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      5/5/25 9:00:20 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form 10-Q filed by Intuitive Surgical Inc.

      10-Q - INTUITIVE SURGICAL INC (0001035267) (Filer)

      4/23/25 5:13:16 PM ET
      $ISRG
      Industrial Specialties
      Health Care